Scioto Biosciences
Preclinical stage company developing innovative therapies devoted to having a transformative impact.
Launch date
Employees
Market cap
-
Enterprise valuation
$106—159m (Dealroom.co estimates Aug 2020.)
Indianapolis Indiana (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$330k | Grant | ||
$1.8m | Series A | ||
$2.3m | Grant | ||
$26.5m | Series B | ||
Total Funding | $30.9m |
Recent News about Scioto Biosciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.